| Fahad Rashid Khan, MD | |
|
800 W Randol Mill Rd, Dept Of Emergency Medicine, Arlington, TX 76012-2504 | |
| (817) 960-6205 | |
| Not Available |
| Full Name | Fahad Rashid Khan |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 800 W Randol Mill Rd, Arlington, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659517233 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 252733 (New York) | Secondary |
| 207P00000X | Emergency Medicine | Q2316 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jewish Hospital - Shelbyville | Shelbyville, KY | Hospital |
| Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
News Archive
Researchers in China have demonstrated the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to interact with the host cell receptors of multiple species of animals.
Leatt®, the company that invented the Leatt-Brace®, is evolving its brand and is showcasing a new logo. Headquartered in Cape Town, South Africa, Leatt is a market leader for design and safety in sports protection.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
The disappearance of an entire brain region should be cause for concern. Yet, for decades scientists have calmly maintained that one brain area, the subplate, simply vanishes during the course of human development.
A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers from Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia.
› Verified 3 days ago
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050302000285 |
News Archive
Researchers in China have demonstrated the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to interact with the host cell receptors of multiple species of animals.
Leatt®, the company that invented the Leatt-Brace®, is evolving its brand and is showcasing a new logo. Headquartered in Cape Town, South Africa, Leatt is a market leader for design and safety in sports protection.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
The disappearance of an entire brain region should be cause for concern. Yet, for decades scientists have calmly maintained that one brain area, the subplate, simply vanishes during the course of human development.
A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers from Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia.
› Verified 3 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740586213 PECOS PAC ID: 5597867184 Enrollment ID: O20070228000503 |
News Archive
Researchers in China have demonstrated the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to interact with the host cell receptors of multiple species of animals.
Leatt®, the company that invented the Leatt-Brace®, is evolving its brand and is showcasing a new logo. Headquartered in Cape Town, South Africa, Leatt is a market leader for design and safety in sports protection.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
The disappearance of an entire brain region should be cause for concern. Yet, for decades scientists have calmly maintained that one brain area, the subplate, simply vanishes during the course of human development.
A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers from Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fahad Rashid Khan, MD 6315 Regiment Pl, Colleyville, TX 76034-5697 Ph: () - | Fahad Rashid Khan, MD 800 W Randol Mill Rd, Dept Of Emergency Medicine, Arlington, TX 76012-2504 Ph: (817) 960-6205 |
News Archive
Researchers in China have demonstrated the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to interact with the host cell receptors of multiple species of animals.
Leatt®, the company that invented the Leatt-Brace®, is evolving its brand and is showcasing a new logo. Headquartered in Cape Town, South Africa, Leatt is a market leader for design and safety in sports protection.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
The disappearance of an entire brain region should be cause for concern. Yet, for decades scientists have calmly maintained that one brain area, the subplate, simply vanishes during the course of human development.
A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers from Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia.
› Verified 3 days ago
Nicholas Keeven, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 Matlock Rd, Arlington, TX 76015 Phone: 682-509-6200 | |
Shane Parker Cole, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Interstate 20 W, Usmd Hosp -- Er Dept, Arlington, TX 76017 Phone: 817-472-3400 | |
Dr. Jon Thomas Beezley, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Randol Mill Rd, Arlington, TX 76012 Phone: 817-548-6205 | |
Dr. Gayla B Garner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 Matlock Rd, Arlington, TX 76015 Phone: 972-758-3598 | |
Shabana Parvez, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4135 Cascade Sky Dr, Arlington, TX 76005 Phone: 682-256-2749 | |
Kristen L Marks, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3301 Matlock Rd, Arlington, TX 76015 Phone: 682-509-4540 Fax: 682-509-4541 | |
Joseph W Nawrocki, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3301 Matlock Rd, Arlington, TX 76015 Phone: 972-758-3598 |